Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, and Neurological Disorders and Treatments.
Blood‐based multivariate methylation risk score for cognitive impairment and dementia
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study
Type-I Interferon drives T-cell responses to Amyloid-beta in the central nervous system
Global estimates on the number of persons across the Alzheimer's disease continuum
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia
A European Academy of Neurology guideline on medical management issues in dementia
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
Bupropion for the Treatment of Apathy in Alzheimer Disease
New use of psychotropic medication after hospitalization among people with dementia
Inflammatory biomarkers in Alzheimer's disease plasma
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease
Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia
On the path to 2025: understanding the Alzheimer’s disease continuum
Consensus guidelines for lumbar puncture in patients with neurological diseases
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
Association Between Later Life Lifestyle Factors and Alzheimer’s Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
Drug development in Alzheimer’s disease: the path to 2025
The European DTI Study on Dementia — A multicenter DTI and MRI study on Alzheimer's disease and Mild Cognitive Impairment
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
Combined treatment with memantine and galantamine‐CR compared with galantamine‐CR only in antidementia drug naïve patients with mild‐to‐moderate Alzheimer's disease
Impaired and preserved aspects of feedback learning in aMCI: contributions of structural connectivity